ATLANTA, May 27, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts regarding the impact of the FDA’s Warning Letter on Viatris’ financials. If you purchased shares of Viatris between August 8, 2024 and February 26, 2025, and experienced a significant loss on that investment, you are e ...